Establishment Labs Holdings Inc.
General ticker "ESTA" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.5B (TTM average)
Establishment Labs Holdings Inc. follows the US Stock Market performance with the rate: 53.2%.
Estimated limits based on current volatility of 3.2%: low 68.80$, high 73.40$
Factors to consider:
- Total employees count: 1018 (+12.1%) as of 2024
- North America accounted for 2.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Reputation and brand risks, Ineffective marketing efforts, Regulatory and compliance, Counterfeit products, Intellectual property risks
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [45.39$, 103.74$]
- 2026-12-31 to 2027-12-31 estimated range: [32.24$, 77.71$]
Financial Metrics affecting the ESTA estimates:
- Negative: with PPE of -42.7 at the end of fiscal year the price was very high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 1.15 <= 3.31
- Positive: Investing cash flow per share per price, % of -0.32 > -0.60
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Positive: Inventory ratio change, % of -2.83 <= -0.75
Short-term ESTA quotes
Long-term ESTA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $165.15MM | $166.03MM | $211.08MM |
| Operating Expenses | $230.18MM | $216.01MM | $250.08MM |
| Operating Income | $-65.03MM | $-49.99MM | $-39.01MM |
| Non-Operating Income | $-13.56MM | $-34.64MM | $-19.01MM |
| Interest Expense | $15.39MM | $20.83MM | $25.26MM |
| R&D Expense | $26.43MM | $19.71MM | $20.25MM |
| Income(Loss) | $-78.58MM | $-84.63MM | $-58.02MM |
| Taxes | $-0.08MM | $-0.03MM | $-6.96MM |
| Net Income(Loss)* | $-78.50MM | $-84.60MM | $-51.06MM |
| Stockholders Equity | $18.39MM | $53.09MM | $23.55MM |
| Inventory | $79.47MM | $78.77MM | $85.61MM |
| Assets | $268.64MM | $346.83MM | $357.17MM |
| Operating Cash Flow | $-88.51MM | $-58.52MM | $-50.89MM |
| Capital expenditure | $24.55MM | $15.56MM | $6.05MM |
| Investing Cash Flow | $-24.55MM | $-15.61MM | $-7.03MM |
| Financing Cash Flow | $86.23MM | $125.89MM | $40.43MM |
| Earnings Per Share** | $-3.07 | $-3.00 | $-1.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.